Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <i>Trypanosoma brucei</i>

Human African trypanosomiasis is among the World Health Organization's designated neglected tropical diseases. Repurposing strategies are often employed in academic drug discovery programs due to financial limitations, and in this instance, we used human kinase inhibitor chemotypes to identify substituted 4-aminoazaindoles, exemplified by <b>1</b>. Structure-activity and structure-property relationship analysis, informed by cheminformatics, identified <b>4s</b> as a potent inhibitor of <i>Trypanosoma brucei</i> growth. While <b>4s</b> appeared to be fast acting and cidal in the <i>in vitro</i> assays, it failed to cure a murine model of infection. Preliminary efforts to identify the potential mechanism of action of the series pointed to arginine kinase, though, as we demonstrate, this does not appear to be the sole target of our compounds. This comprehensive approach to drug discovery, encompassing cheminformatics, structure-potency and structure-property analysis, and pharmacophore identification, highlights our multipronged efforts to identify novel lead compounds for this deadly disease.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2024-08-13
DOI
https://doi.org/10.1021/acs.jmedchem.4c00785
Citations
1
Primary Topic
Trypanosoma species research and implications
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma brucei

Antonio Quotadamo, Uma Swaminathan, Andreu Saura, Gloria Ceballos-Pérez et al.
1 citations
Journal of Medicinal Chemistry
Trypanosoma species research and implications
0.39
article

Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma brucei

Antonio Quotadamo, Uma Swaminathan, Andreu Saura, Gloria Ceballos-Pérez, Guiomar Pérez‐Moreno, Dolores González‐Pacanowska, Miguel Navarro, Lori Ferrins, Claudia Gómez-Liñán, Michael P. Pollastri, Maria Santos Martínez, Cristina Bosch‐Navarrete, Raquel García‐Hernández, Daniel P. Oehme, Francisco Gamarro, Domingo I. Rojas-Barros, Rosario Díaz-González, Carlos Cordón-Obras, Luis M. Ruiz‐Pérez, Pilar Manzano
article en
1 citations

Abstract

Human African trypanosomiasis is among the World Health Organization's designated neglected tropical diseases. Repurposing strategies are often employed in academic drug discovery programs due to financial limitations, and in this instance, we used human kinase inhibitor chemotypes to identify substituted 4-aminoazaindoles, exemplified by <b>1</b>. Structure-activity and structure-property relationship analysis, informed by cheminformatics, identified <b>4s</b> as a potent inhibitor of <i>Trypanosoma brucei</i> growth. While <b>4s</b> appeared to be fast acting and cidal in the <i>in vitro</i> assays, it failed to cure a murine model of infection. Preliminary efforts to identify the potential mechanism of action of the series pointed to arginine kinase, though, as we demonstrate, this does not appear to be the sole target of our compounds. This comprehensive approach to drug discovery, encompassing cheminformatics, structure-potency and structure-property analysis, and pharmacophore identification, highlights our multipronged efforts to identify novel lead compounds for this deadly disease.

Journal of Medicinal ChemistryVol. 67(16)
University of Modena and Reggio Emilia (IT), Northeastern University (US), Consejo Superior de Investigaciones Científicas (ES), Instituto de Parasitología y Biomedicina "López - Neyra" (ES)
Ministerio de Ciencia, Innovación y Universidades, Red de Investigación Cooperativa en Enfermedades Tropicales, Instituto de Salud Carlos III, European Regional Development Fund, National Institute of Allergy and Infectious Diseases
Zero hunger
Openalex Percentile: Top 35%
Trypanosoma species research and implications
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.